BOD.ASX: Appendix 4C Cash Flow Report

Appendix 4C Cash Flow Report

Stock	BOD Science Ltd (BOD.ASX)
Release Time	22 Jul 2025, 3:54 p.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

BOD Science Ltd Releases Q4 2025 Cash Flow Report

Key Points

Receipts from customers increased to $1.2M for the year
R&D tax incentive of $678K received during the quarter
Funding from Biortica Agrimed Limited to support ongoing trading costs

Full Summary

BOD Science Ltd has released its Appendix 4C Quarterly Cash Flow Report for the quarter ended 30 June 2025. The report shows that the company received $388K in customer receipts during the quarter, bringing the total for the year to $1.2M. The company also received a $678K R&D tax incentive payment during the quarter, of which $400K is held in trust for the benefit of Biortica Agrimed Limited (Biortica) if the acquisition of BOD by Biortica completes. Additionally, in accordance with the Heads of Agreement between BOD and Biortica signed in February 2024, Biortica has partially funded the ongoing trading costs of BOD, which have been disclosed as other inflows from operating activities. The company's cash and cash equivalents at the end of the quarter stood at $1.037M.